The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Items 401–500 of 728
Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis
Cao, W. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000212 · Cited by 20
“Remarkably, heterozygous mutations in TREX1 represent the single most common cause of monogenic lupus and mice lacking Trex1 develop a severe multiorgan autoimmune disease that is driven by IFN from non-hematopoietic cells [66,67].”
BackgroundNakaoka, H., Cui, T., Tajima, A., Oka, A., Mitsunaga, S., Kashiwase, K., Homma, Y., Sato, S., Suzuki, Y., Inoko, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025389 · Cited by 21
Designation of Autoinflammatory Skin Manifestations With Specific Genetic Backgrounds
Kanazawa, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00475 · Cited by 19
Drobek, A., Bernaleau, L., Delacrétaz, M., Calderon-Copete, S. P., Royer-Chardon, C., Longepierre, M., Tortajada, M., Korzeniowski, J., Rotman, S., Marquis, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55692-y · Cited by 22
Kang, Y. (2018) · BioEssays · doi:10.1002/bies.201800058 · Cited by 19
Palmitoylation in Crohn’s disease: Current status and future directions
Cheng, W.-X., Ren, Y., Lu, M.-M., Xu, L.-L., Gao, J., Chen, D., Kalyani, F. S., Lv, Z., Chen, C., Ji, F., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i48.8201 · Cited by 20
Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus
Radic, M. Z., Neeli, I., & Marion, T. N. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2026921 · Cited by 18
“Mutations in early complement components, especially C1q [11–13], and the cytosolic endonuclease TRX1 [14], although rare, are strong risk factors for SLE (OR = 10 and 25, respectively).”
Background‘From R-lupus to cancer’: Reviewing the role of R-loops in innate immune responses
Bradley, L., & Savage, K. I. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103581 · Cited by 19
Deng, Y., Zhao, J. H., Sakurai, D., Sestak, A. L., Osadchiy, V., Langefeld, C. D., Kaufman, K. M., Kelly, J. A., James, J. A., Petri, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208441 · Cited by 18
Self-citationNucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus
Günther, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01636 · Cited by 20
“Heterozygous TREX1 mutations enhance the risk for the development of SLE (36).”
BackgroundManils, J., Fischer, H., Climent, J., Casas, E., Garcia‐Martínez, C., Bas, J., Sukseree, S., Vavouri, T., Ciruela, F., de Anta, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12308-4 · Cited by 22
Autoimmunity caused by constitutive activation of cytoplasmic viral RNA sensors
Kato, H., & Fujita, T. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.08.003 · Cited by 18
Ahlers, L. R. H., & Goodman, A. G. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0043-5 · Cited by 17
O’Donovan, D. H., Mao, Y., & Mele, D. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620103105 · Cited by 19
The Danger Model Approach to the Pathogenesis of the Rheumatic Diseases
Pacheco‐Tena, C., & González‐Chávez, S. A. (2015) · Journal of Immunology Research · doi:10.1155/2015/506089 · Cited by 18
Host DNase TREX1 hides HIV from DNA sensors
Geijtenbeek, T. B. H. (2010) · Nature Immunology · doi:10.1038/ni1110-979 · Cited by 21
Perrino, F. W., de Silva, U., Harvey, S. E., Pryor, E. E., Cole, D. W., & Hollis, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803629200 · Cited by 17
Self-citationRecognize Yourself—Innate Sensing of Non-LTR Retrotransposons
Lagisquet, J., Zuber, K., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13010094 · Cited by 20
“Interestingly, in some cases of SLE, TREX1 deficiency has been linked to the disease, suggesting a similar mechanism of triggering autoimmune responses in SLE and AGS [55,56].”
BackgroundcGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice
Li, T., Yum, S., Wu, J., Li, M., Deng, Y., Sun, L., Zuo, X., & Chen, Z. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411747121 · Cited by 21
Guo, F., Zhang, J., Gao, Y., Shu, Z., Sun, F., Ma, J., Zhou, X., Li, W., Mao, H., & Lei, X. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202407641 · Cited by 24
Heterozygous TREX1 mutations in early-onset cerebrovascular disease
Pelzer, N., Vries, B., Boon, E. M. J., Kruit, M. C., Haan, J., Ferrari, M. D., van den Maagdenberg, A. M. J. M., & Terwindt, G. M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7050-8 · Cited by 16
Ma, Z., Xiong, Q., Xia, H., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1972198 · Cited by 16
“The TREX1 mutations have been associated with various complications, including systemic lupus erythematosus and cardiomyopathy [13].”
BackgroundSystems approaches to human autoimmune diseases
Banchereau, R., Cepika, A., & Pascual, V. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.08.005 · Cited by 19
“As 50% of AGS patients develop lupus symptoms, TREX1 variants were sought after and found in up to 2% of patients with nonfamilial SLE, revealing the importance of the cytosolic nucleic acid sensing pathway in this disease [66].”
BackgroundDNA binding induces active site conformational change in the human TREX2 3'-exonuclease
de Silva, U., Perrino, F. W., & Hollis, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp025 · Cited by 20
“The TREX1 protein contains an extended C-terminal domain of about 76 amino acids not present in TREX2 that plays a putative role in anchoring TREX1 to the cytosolic side of the ER membrane ( 12 ).”
BackgroundSelf-citationDNA damage-induced inflammation and nuclear architecture
Stratigi, K., Chatzidoukaki, O., & Garinis, G. A. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.008 · Cited by 18
Rossano, M., Conti, E. A., Bocca, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1288675 · Cited by 15
Ritchie, C., & Li, L. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.001 · Cited by 17
Genetic Variation and Epigenetic Patterns in Autoimmunity
Hedrich, C. M. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.10000e2 · Cited by 15
Rhodes, B., & Vyse, T. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00080-x · Cited by 18
Self-citationFye, J. M., Coffin, S. R., Orebaugh, C. D., Hollis, T., & Perrino, F. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559252 · Cited by 17
“Additionally, heterozygous TREX1 mutations in systemic lupus erythematosus (23, 25) and retinal vasculopathy with cerebral leukodystrophy (20) locate outside the catalytic domain in the C-terminal region potentially leading to dominant non-catalytic dysfunction related to cellular localization or protein interactions…”
BackgroundSelf-citationTaking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?
Pawaria, S., Sharma, S., Baum, R., Nündel, K., Busto, P., Gravallese, E. M., Fitzgerald, K. A., & Marshak‐Rothstein, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-115r · Cited by 17
“Genetic associations between TREX1 mutations and SLE in patient populations [47, 48] potentially implicate STING in additional instances of systemic autoimmunity.”
BackgroundType I interferons in health and disease: molecular aspects and clinical implications
Mavragani, C. P., & Crow, M. K. (2025) · Physiological Reviews · doi:10.1152/physrev.00047.2024 · Cited by 22
Systemic lupus erythematosus and immunodeficiency
Chan, S. C. W., & Lau, C. S. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0019 · Cited by 19
Rösing, S., Ullrich, F., Meisterfeld, S., Schmidt, F., Mlitzko, L., Croon, M., Nattrass, R. G., Eberl, N., Mahlberg, J., Schlee, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45535-1 · Cited by 19
A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses
Flowers, S. J., Petronella, B. A., McQueney, M. S., Fanelli, B., Eisenberg, W., Uveges, A. J., Roden, A. L., Salowe, S. P., Bommireddy, V., Letourneau, J. J., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305962 · Cited by 14
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
Akazawa, S., Mackin, L., Jhala, G., Fynch, S., Catterall, T., Selck, C., Graham, K. L., Krishnamurthy, B., Pappas, E. G., Kwong, C.-T. J., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05378-z · Cited by 15
Le lupus systémique à début pédiatrique : une pathologie polygénique ou monogénique ?
Bader‐Meunier, B., Jeremiah, N., & Rieux‐Laucat, F. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.10.370 · Cited by 15
Harsini, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00001-3 · Cited by 13
Les interféronopathies de type I. Mise au point et revue de la littérature
Picard, C., & Bélot, A. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.08.016 · Cited by 15
Tarbell, K. V., & Egen, J. G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1017-400r · Cited by 16
Rare genetic variants in systemic autoimmunity
Jiang, S., Stanley, M., & Vinuesa, C. G. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12339 · Cited by 15
“Several large-scale efforts have used next-generation sequencing technologies to investigate the contribution of common and rare variants to SLE.”
BackgroundInfluentialVenkatadri, R., Sabapathy, V., Doğan, M., Mohammad, S., Harvey, S. E., Simpson, S. R., Grayson, J. M., Yan, N., Perrino, F. W., & Sharma, R. (2022) · European Journal of Immunology · doi:10.1002/eji.202149324 · Cited by 13
“Tfh dysregulation can facilitate proautoimmune GC responses observed in SLE patients [15, 20, 44].”
BackgroundInfluentialSelf-citationMonogenic lupus: Tracing the therapeutic implications from single gene mutations
Jia, X., Tan, L., Chen, S., Tang, R., & Chen, W. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109699 · Cited by 15
Deng, Y., & Tsao, B. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00005-0 · Cited by 16
Detection of novel 3' untranslated region extensions with 3' expression microarrays
Thorrez, L., Tranchevent, L.-C., Chang, H. J., Moreau, Y., & Schuit, F. C. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-205 · Cited by 13
“Mutations in the 3’ UTR region have been associated with many diseases such as systemic lupus erythematosus [21,22], spastic paraplegia [23] and cardiomyopathy [24].”
BackgroundIdentification of Small-Molecule Inhibitors of the Ribonuclease H2 Enzyme
White, R., SAXTY, B. A., Large, J. M., Kettleborough, C. A., & Jackson, A. P. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113476550 · Cited by 13
“Notably, mutations in TREX1, one of the other nucleases causing AGS, are found in a proportion of SLE patients.(14) RNase H2 has also been suggested as a putative anticancer drug target, based on its overexpression in cancer cell lines and findings of a genome-wide siRNA screen.”
BackgroundAicardi-Goutières Syndrome: Cutaneous, Laboratory, and Radiologic Findings: A Case Report
Juern, A. M., Robbins, A. C., Galbraith, S. S., & Drolet, B. A. (2010) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.01055.x · Cited by 13
Cifuentes‐González, C., Tong, Y. L., Mejía‐Salgado, G., Chan, R., Walter, C. F. Y., Rojas-Carabali, W. A., Putera, I., Mobasserian, A., Nora, R. L. D., Biswas, J., et al. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.01.012 · Cited by 12
Skeldon, A. M., Wang, L., Sgarioto, N., Beveridge, R. E., Chan, S. Y. T., Dorich, S., Dumais, V., Fradet, N., Gaudreault, S., LeGros, P., et al. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01481-7 · Cited by 13
“De fi ciencies in TREX1 , an exonuclease that regulates cytoplasmic dsDNA levels and consequently cGAS activity, has been genetically linked with the type I interferonopathy Aicardi-Goutières syndrome (AGS), systemic lupus erythematosus (SLE), and familial chilblain lupus 9 – 12 .”
Discovery of 3,4-dihydroisoquinoline-2(1H)-carboxamide STING inhibitors as anti-inflammatory agents
Zhou, X., Yue, H., Wang, X., Zang, S., Han, L., Yao, S., Geng, M., Zhan, Z., Xie, Z., & Duan, W. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117922 · Cited by 14
Aicardi-Goutières syndrome with emphasis on sonographic features in infancy
Rößler, L., Ludwig-Seibold, C., Thiels, C., & Schaper, J. (2012) · Pediatric Radiology · doi:10.1007/s00247-012-2384-4 · Cited by 12
Baum, R., Nündel, K., Pawaria, S., Sharma, S., Busto, P., Fitzgerald, K. A., Gravallese, E. M., & Marshak‐Rothstein, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502130 · Cited by 12
Les syndromes lupiques monogéniques
Bélot, A., & Cochat, P. (2011) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2011.05.003 · Cited by 11
B Cell Tolerance and Positive Selection in Lupus
Eilat, D., & Wabl, M. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200848 · Cited by 14
STING-mediated DNA sensing in cancer immunotherapy
Zhou, X., & Jiang, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9066-0 · Cited by 13
Genetic analysis reveals novel variants for vascular cognitive impairment
Mönkäre, S., Kuuluvainen, L., Schleutker, J., Brás, J., Roine, S., Pöyhönen, M., Guerreiro, R. J., & Myllykangas, L. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13613 · Cited by 13
Intracellular Sensing of DNA in Autoinflammation and Autoimmunity
MacLauchlan, S., Fitzgerald, K. A., & Gravallese, E. M. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42256 · Cited by 13
Clinical Perspectives on Lupus Genetics
James, J. A. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.002 · Cited by 17
TREX1 exonuclease in immunity and disease
Shang, Z., Wang, L., & Zhou, W. (2025) · International Immunology · doi:10.1093/intimm/dxaf037 · Cited by 16
Prime Editing: Mechanistic Insights and DNA Repair Modulation
Mentani, A., Maresca, M., & Shiriaeva, A. (2025) · Cells · doi:10.3390/cells14040277 · Cited by 15
Agrawal, R., Tarannum, N., Chourasia, M., & Soni, R. K. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-017-0987-4 · Cited by 12
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling
Shim, A., Luan, X., Zhou, W., Crow, Y. J., & Maciejowski, J. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae089 · Cited by 10
“Deleting this C-terminal extension ablates TREX1 ER localization but does not affect its catalytic activity (21,23).”
Lamas, A., Faria, R., Marinho, A., & Vasconcelos, C. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103675 · Cited by 15
Myeloid cells as IFNα producers in systemic lupus erythematosus
Kuga, T., Chiba, A., Murayama, G., & Miyake, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562221 · Cited by 10
“Genetic de fi ciencies of nucleic acid degradation molecules, such as extracellular DNase-I and TREX1, the most abundant 3 ’ → 5 ’ DNA exonuclease in cells, are associated with a lupus-like syndrome in mice and humans (16 – 18).”
Liu, Y., Li, Y., Xue, L., Xiao, J., Li, P., Xue, W., Li, C., Guo, H., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033982 · Cited by 11
“IFN-1 is an important link in the progression of SLE and is secreted mainly by dendritic cells and plasma cells (Murayama et al., 2020; Thim-Uam et al., 2020).”
BackgroundB-Lymphocyte Signalling Abnormalities and Lupus Immunopathology
Taher, T. E. I., Muhammad, H. A., Bariller, E., Flores‐Borja, F., Renaudineau, Y., Isenberg, D. A., & Mageed, R. A. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.788648 · Cited by 12
SLE redefined on the basis of molecular pathways
Barturen, G., & Alarcón-Riquelme, M. E. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.006 · Cited by 9
“In addition, SLE patients showing chilblain skin signs have an excess of TREX1 mutations [44].”
BackgroundRutherford, H. A., Kasher, P. R., & Hamilton, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623650 · Cited by 12
Aviña-Zubieta, J. A., Daftarian, N., & Esdaile, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00062-9 · Cited by 11
Ramantani, G., Niggemann, P., Bast, T., & Lee‐Kirsch, M. A. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2147 · Cited by 10
Self-citationvan der Made, C. I., Hoischen, A., Netea, M. G., & van de Veerdonk, F. L. (2020) · Immunological Reviews · doi:10.1111/imr.12898 · Cited by 11
Lewandowski, L., Hiraki, L., Scott, C., Barrera-Vargas, A., Tena, J. R., Gómez-Martín, D., Ombrello, M., Aksentijevich, I., Deng, Z.-M., Musolf, A., et al. (2025) · Lupus Science and Medicine · doi:10.1136/lupus-2024-001475 · Cited by 9
What can we learn from DNA methylation studies in lupus?
Ferreté-Bonastre, A. G., Cortés-Hernández, J., & Ballestar, E. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108920 · Cited by 10
Mistry, V., Bockett, N. A., Levine, A. P., Mirza, M. M., Hunt, K. A., Ciclitira, P. J., Hummerich, H., Neuhausen, S. L., Simpson, M. A., Plagnol, V., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116845 · Cited by 12
“Other examples of rare coding variants in common disease are ANGPTL4 in high-density lipoprotein cholesterol levels, IFIHI in T1D, TREX1 in systemic lupus erythematosus, and CARD14 in psoriasis [19,20,24,25].”
BackgroundWang, Y., Ma, Q., & Huo, Z. (2021) · Medicine · doi:10.1097/md.0000000000026499 · Cited by 12
“Nucleic acid degradation is associated with monogenic forms of lupus-like disease.([3,4]) Additionally, thrombosis is often induced in the process of SLE.”
BackgroundHuman TREX1 Repairs 3′-End DNA Lesions in Vitro
Yang, K., Wei, X., Le, J., et al. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00087 · Cited by 9
Update on R-loops in genomic integrity: Formation, functions, and implications for human diseases
Zhu, M., Wang, X., Zhao, H., & Wang, Z. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101401 · Cited by 16
Bélot, A., Tusseau, M., Cognard, J., Georgin‐Lavialle, S., Boursier, G., & Hedrich, C. M. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70003 · Cited by 8
Gilbert, M., & Punaro, M. (2014) · Pediatric Rheumatology · doi:10.1186/1546-0096-12-16 · Cited by 8
“The spectrum of disease associated with these mutations is not yet fully defined, but one study reports approximately 2% of SLE patients have mutations in the gene encoding the TREX1 exonuclease [46], mutations which can cause AGS.”
BackgroundGenetik des Lupus erythematodes
Günther, C. (2015) · Der Hautarzt · doi:10.1007/s00105-014-3570-0 · Cited by 7
Typ-I-Interferonopathien: Durch Typ-1-Interferone bedingte entzündliche Systemerkrankungen
Günther, C., Schmidt, F., König, N., & Lee‐Kirsch, M. A. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-015-0027-5 · Cited by 11
Self-citationLee, H., Heo, J., Myung, S., Shin, I., & Kim, T. H. (2017) · Electroanalysis · doi:10.1002/elan.201700006 · Cited by 8
Genome Replication Is Associated With Release of Immunogenic DNA Waste
Schubert, N., Schumann, T., Daum, E., Flade, K., Ge, Y., Hagedorn, L., Edelmann, W., Müller, L., Schmitz, M., Kuut, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880413 · Cited by 10
“While homozygous loss of Trex1 results in AGS, heterozygous Trex1 loss-of-function alleles are associated with systemic lupus erythematosus (SLE), contributing to the polygenic predisposition for this severe autoimmune disease (17).”
BackgroundEugster, A., Müller, D., Gompf, A., Reinhardt, S., Lindner, A., Ashton, M. P., Zimmermann, N., Beissert, S., Bonifacio, E. E., & Günther, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897500 · Cited by 9
“Further analyzing type I IFN-responding cell subtypes in monogenic types of lupus will help understanding the development of autoimmunity due to TREX1 mutations and will shed light on other types of SLE induced by similar disturbance in intracellular nucleic acid metabolism.”
BackgroundInfluentialInteractions Between HIV-1 and Innate Immunity in Dendritic Cells
Silvin, A., & Manel, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_7 · Cited by 12
Solving the genetic puzzle of systemic lupus erythematosus
Yang, W., & Lau, Y. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2947-8 · Cited by 8
“Detection of rare mutations inDNASE1 [48], TREX1 [50, 74], andC1q,C2, and C4 [47], which cause Mendelian types of SLE, do lend support to this notion.”
BackgroundInfluentialAicardi–Goutières syndrome with systemic lupus erythematosus and hypothyroidism
Kamei, A., Akasaka, M., Soga, N., et al. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.03.012 · Cited by 8
Paediatric systemic lupus erythematosus: insights from translational research
Wright, T. B., & Punaro, M. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kew447 · Cited by 8
Rare variants of the 3’-5’ DNA exonuclease TREX1 in early onset small vessel stroke
McGlasson, S. L., Rannikmäe, K., Bevan, S., Logan, C., Bicknell, L. S., Jury, A., Study, U. Y. L. S., Jackson, A. P., Markus, H. S., Sudlow, C. L. M., et al. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12631.1 · Cited by 8
Protein-protein interactions in cGAS-STING pathway: a medicinal chemistry perspective
Zhang, S.-D., Li, H., Zhou, Y.-L., Liu, X., Li, D.-C., Hao, C.-F., You, Q., & Xu, X. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2383164 · Cited by 7
Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response
Zhu, Y. D., Castrillon, C. E., & Carroll, M. C. (2025) · Immunological Reviews · doi:10.1111/imr.70005 · Cited by 7
“Nuclease deficiencies, such as functionally disrupted intracellular exonuclease TREX-1 and endonuclease DNase II, were associated with SLE and RA [50–55].”
Wang, Y., Luo, W., Wu, W., Chen, C., Qin, B., Xu, X., Xu, Y., Zeng, J., Wang, L., Yang, J., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107817 · Cited by 9
Tupik, J. D., Madanick, J. M., Ivester, H. M., & Allen, I. C. (2022) · Cells · doi:10.3390/cells11101681 · Cited by 9
“Overexpression of STING has been implicated in autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and Aicardi–Goutières syndrome [44].”
BackgroundVasculitis and vasculopathy associated with inborn errors of immunity: an overview
Federici, S., Cinicola, B. L., Torre, F. L., Castagnoli, R., Lougaris, V., Giardino, G., Volpi, S., Caorsi, R., Leonardi, L., Corrente, S., et al. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1258301 · Cited by 11
Etiology and Pathogenesis of Systemic Lupus Erythematosus
Crow, M. K. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00079-7 · Cited by 13
Karanja, C. W., Yeboah, K. S., Ong, W. W. S., & Sintim, H. O. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00187b · Cited by 10
The Enzyme Portal: an integrative tool for enzyme information and analysis
Zaru, R., Onwubiko, J., Ribeiro, A. J. M., Cochrane, K., Tyzack, J. D., Muthukrishnan, V., Pravda, L., Thornton, J. M., O’Donovan, C., Velanker, S., et al. (2021) · FEBS Journal · doi:10.1111/febs.16168 · Cited by 7
Tsao, B. P., & Deng, Y. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10003-8 · Cited by 7
Aberrant B ‐lymphocyte responses in lupus: inherent or induced and potential therapeutic targets
Taher, T. E. I., Muhammad, H. A., Rahim, A., Flores‐Borja, F., Renaudineau, Y., Isenberg, D. A., & Mageed, R. A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12111 · Cited by 7
Kutaner Lupus erythematodes und Hautveränderungen beim systemischen Lupus erythematodes
Sticherling, M. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1134-9 · Cited by 7
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.